- Investing Ideas
- Global Pharmaceuticals & Biotech Spotless Management
Global Pharmaceuticals & Biotech Spotless Management
Results
7
Well rounded companies, with acceptable leverage, projected to deliver an ROE north of 20% in three years.
7 companies
AstraZeneca
Market Cap: UK£179.3b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZN
UK£115.60
7D
-3.6%
1Y
-1.5%
Chugai Pharmaceutical
Market Cap: JP¥11.3t
Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.
4519
JP¥6,854.00
7D
-3.6%
1Y
4.8%
Orion Oyj
Market Cap: €11.0b
Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.
ORNBV
€78.05
7D
-1.1%
1Y
12.8%
Shanghai Allist Pharmaceuticals
Market Cap: CN¥54.0b
A pharmaceutical company, engages in the research and development of tumor-targeted drugs in China in internationally.
688578
CN¥118.84
7D
0.7%
1Y
32.1%
Xiamen Amoytop Biotech
Market Cap: CN¥23.9b
Engages in research, development, production, and sale of recombinant protein drugs in China and internationally.
688278
CN¥60.16
7D
-0.5%
1Y
-31.2%
Laboratorios Farmaceuticos Rovi
Market Cap: €2.9b
Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.
ROVI
€57.60
7D
-1.9%
1Y
0.6%
PharmaResearch
Market Cap: ₩4.1t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩393,000.00
7D
-5.8%
1Y
-41.8%